Palvella Therapeutics PVLA
NASDAQ PVLA
$132.47 -0.26 (-0.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

Palvella Therapeutics (PVLA) Long-Term Investments (2017 - 2022)

Updated

Palvella Therapeutics (PVLA) reported Long-Term Investments of $26.68 million for Q2 2022, up 97.2% from the prior quarter.

Analysis

Palvella Therapeutics (PVLA) Long-Term Investments (2017 - 2022) Analysis & Trends

At the end of FY2019, Palvella Therapeutics posted Long-Term Investments of $41.89 million.

  • By year, Long-Term Investments came in at $9.92 million in FY2017.
  • The Q2 2022 figure ranks as the highest quarterly Long-Term Investments since Q2 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 266.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 2.62 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.56 Bn
10 Palvella Therapeutics 1.91 Bn 1.66 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 26.68 Mn
Mar 31, 2022 13.53 Mn
Sep 30, 2020 15.75 Mn
Jun 30, 2020 32.91 Mn
Mar 31, 2020 39.33 Mn
Dec 31, 2019 41.89 Mn
Sep 30, 2019 40.18 Mn
Jun 30, 2019 44.78 Mn
Mar 31, 2019 58.69 Mn
Jun 30, 2018 700,000.00
Mar 31, 2018 2.58 Mn
Dec 31, 2017 9.92 Mn
API Access

Palvella Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=PVLA&period=max&api_key=YOUR_API_KEY